10
Participants
Start Date
April 20, 2022
Primary Completion Date
December 31, 2027
Study Completion Date
March 31, 2028
Impella BTR
Subjects will be prepared for pump insertion procedure according to clinical site standard of care. Procedural preparations for insertion of the Impella BTR are identical to the insertion of the Impella 5.0/5.5 via the axillary artery. The Impella BTR remains in situ until the patient is sufficiently recovered for removal or is transitioned to another form of support. It is expected that the Impella BTR is in situ for a maximum of 28 days.
Emory University Hospital, Atlanta
Cleveland Clinic, Cleveland
Northwestern University, Evanston
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Hackensack University Medical Center, Hackensack
Lead Sponsor
Abiomed Inc.
INDUSTRY